» Articles » PMID: 22277941

Epitope Spreading is Rarely Found in Pemphigus Vulgaris by Large-scale Longitudinal Study Using Desmoglein 2-based Swapped Molecules

Overview
Publisher Elsevier
Specialty Dermatology
Date 2012 Jan 27
PMID 22277941
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Epitope spreading is involved in inducing and maintaining self-reactivity. Epitope spreading in pemphigus vulgaris (PV), caused by IgG autoantibodies to desmoglein 3 (Dsg3) and Dsg1, was previously analyzed using Dsg3/Dsg1 extracellular domain-swapped molecules. However, precise identification of the responsible epitopes in each molecule by using only this method was problematic. In this study, we studied epitope spreading in PV by a novel immunoprecipitation-immunoblot method using Dsg3 (or Dsg1)/Dsg2 domain-swapped molecules, which overcomes the problems associated with the previous approaches. We analyzed the antigenic epitopes recognized by 212 sera collected from 53 PV patients at multiple disease stages. The major epitopes were present at the N-terminal region of Dsgs and were unchanged over the course of the disease in both anti-Dsg3 mucosal dominant-type PV and anti-Dsg3/Dsg1 mucocutaneous-type PV. These N-terminal epitopes were calcium dependent. Circulating antibodies in paraneoplastic pemphigus and pemphigus herpetiformis had unique epitope distributions, although the Dsg N-termini still contained the major epitopes. These results suggest that, after onset, intramolecular and intermolecular epitope spreading among extracellular domains on Dsg3 and Dsg1 is rare in PV and has no correlation with disease course.

Citing Articles

Pemphigus relapse: Mechanisms, risk factors, and agents associated with disease recurrence.

Pathak G, Agarwal P, Wolfe S, Patel K, Dhillon J, Rao B J Dermatol. 2024; 51(12):1533-1546.

PMID: 39460496 PMC: 11624153. DOI: 10.1111/1346-8138.17505.


Quality-controlled characterization of a monoclonal antibody specific to an EC5-domain of human desmoglein 3 for pemphigus research.

Eming R, Riaz S, Muller E, Zakrzewicz A, Linne U, Tikkanen R Front Immunol. 2024; 15:1464881.

PMID: 39450179 PMC: 11499099. DOI: 10.3389/fimmu.2024.1464881.


CAR-Based Therapy for Autoimmune Diseases: A Novel Powerful Option.

Muzes G, Sipos F Cells. 2023; 12(11).

PMID: 37296654 PMC: 10252902. DOI: 10.3390/cells12111534.


Dsg3 epitope-specific signalling in pemphigus.

Schmitt T, Hudemann C, Moztarzadeh S, Hertl M, Tikkanen R, Waschke J Front Immunol. 2023; 14:1163066.

PMID: 37143675 PMC: 10151755. DOI: 10.3389/fimmu.2023.1163066.


Role of Rituximab in the Treatment of Pemphigus Vulgaris: Patient Selection and Acceptability.

Ciolfi C, Sernicola A, Alaibac M Patient Prefer Adherence. 2022; 16:3035-3043.

PMID: 36387051 PMC: 9651071. DOI: 10.2147/PPA.S350756.